[
  {
    "ts": "2026-01-22T00:02:43+00:00",
    "headline": "J&J's Guidance Wallops Views, But Boston Scientific, Medtronic Take A Toll",
    "summary": "Johnson & Johnson stock dipped Wednesday despite a fourth-quarter beat as Medtronic and Boston Scientific continued gaining share in PFA.",
    "url": "https://www.investors.com/news/technology/johnson-and-johnson-stock-jnj-earnings-q4-2025/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "2a14968b-af49-395f-8455-489539a6620c",
      "content": {
        "id": "2a14968b-af49-395f-8455-489539a6620c",
        "contentType": "STORY",
        "title": "J&J's Guidance Wallops Views, But Boston Scientific, Medtronic Take A Toll",
        "description": "",
        "summary": "Johnson & Johnson stock dipped Wednesday despite a fourth-quarter beat as Medtronic and Boston Scientific continued gaining share in PFA.",
        "pubDate": "2026-01-22T00:02:43Z",
        "displayTime": "2026-01-22T00:02:43Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/2a14968b-af49-395f-8455-489539a6620c/j-j-s-guidance-wallops-views-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/0ae2b2db37883f68ee2069be9bd594e4",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rwA2Kba4.xjpNvtEg7n9QQ--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/0ae2b2db37883f68ee2069be9bd594e4.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9I9e__rmE38egilIIeIqrQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/0ae2b2db37883f68ee2069be9bd594e4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/news/technology/johnson-and-johnson-stock-jnj-earnings-q4-2025/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "MDT"
            }
          ],
          "premiumFinance": null
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-22T02:50:00+00:00",
    "headline": "Is This Dividend King Stock a Buy After a Major Development?",
    "summary": "After a strong performance in 2025, Johnson & Johnson is starting the new year right.",
    "url": "https://www.fool.com/investing/2026/01/21/is-this-dividend-king-stock-a-buy-after-a-major-de/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "1ce0c2ea-6a06-3795-8dc7-008936c4dd84",
      "content": {
        "id": "1ce0c2ea-6a06-3795-8dc7-008936c4dd84",
        "contentType": "STORY",
        "title": "Is This Dividend King Stock a Buy After a Major Development?",
        "description": "",
        "summary": "After a strong performance in 2025, Johnson & Johnson is starting the new year right.",
        "pubDate": "2026-01-22T02:50:00Z",
        "displayTime": "2026-01-22T02:50:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/09236348b2e17cadeda32e51081d92e5",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "Doctor and patient in a hospital room.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZVsnfs15n5_MVdj0fOur4g--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/09236348b2e17cadeda32e51081d92e5.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/8rzPV9pz9Clq_QNJVtYrFQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/09236348b2e17cadeda32e51081d92e5.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/01/21/is-this-dividend-king-stock-a-buy-after-a-major-de/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/dividend-king-stock-buy-major-025000516.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]